CDK8-IN-4 |
| Katalog-Nr.GC33366 |
CDK8-IN-4 ist ein Inhibitor von CDK8, extrahiert aus Patent WO2014090692A1, Verbindungsbeispiel 16, mit einem IC50 von 0,2 nM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1613638-82-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CDK8-IN-4 is an inhibitor of CDK8 extracted from patent WO2014090692A1, compound example 16, with an IC50 of 0.2 nM.
[1]. Cheng Z, et al. Novel bi-ring phenyl-pyridines/pyrazines for the treatment of cancer. WO2014090692A1
Review for CDK8-IN-4
Average Rating: 5 (Based on Reviews and 13 reference(s) in Google Scholar.)
Review for CDK8-IN-4
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *